Risk communication: Why, what and how?

Diabetes and Primary Care

Volumn 12, Issue 2, 2010, Pages 100-104

  Price, Hermione ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Communication; Psychological impact; Risk assessment

Indexed keywords

EID: 84866412988     PISSN: 14668955     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ancker JS, Senathirajah Y, Kukafka R, Starren JB (2006) Design features of graphs in health risk communication: a systematic review. J Am Med Inform Assoc 13: 608-18 (Pubitemid 44649360)
2. Asimakopoulou K, Skinner T, Fox C et al (2007) Risk communication in type 2 diabetes (T2D): the effects of using different time-frames of communicating risk of coronary heart disease (CHD) and stroke on patients' understanding and memory of these risks. Diabet Med 24(Suppl 1): 95
3. Atkins CD (1997) Translating statistics for use in the clinic. J Gen Intern Med 12: 626-8
4. Axworthy D, Brock DJ, Bobrow M, Marteau TM (1996) Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. UK Cystic Fibrosis Follow-Up Study Group. Lancet 347: 1443-6 (Pubitemid 26161207)
5. Calman KC (2002) Communication of risk: choice, consent, and trust. Lancet 360: 166-8
6. Colhoun HM, Betteridge DJ, Durrington PN et al (2004) Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364: 685-96 (Pubitemid 39140624)
7. Curry SJ, Taplin SH, Anderman C et al (1993) A randomized trial of the impact of risk assessment and feedback on participation in mammography screening. Prev Med 22: 350-60 (Pubitemid 23183080)
8. Davies M, Khunti K, Chauhan U et al (2008) UK National Screening Committee: The handbook for vascular risk assessment, risk reduction and risk management. UK National Screening Committee and Univetsity of Leicester, Leicester
9. Durack-Bown I, Giral P, d'Ivernois JF (2003) Patients' and physicians' perceptions and experience of hypercholesterolaemia: a qualitative study. Br J Gen Pract 53: 851-7 (Pubitemid 37383806)
10. Edwards A (2007) IMP 3-16 Edwards: A Systematic Review of Risk Communication - Improving Effective Clinical Practice and Research in Primary Care. Department of Health, London
11. Edwards A, Elwyn G (1999) How should effectiveness of risk communication to aid patients' decisions be judged? A review of the literature. Med Decis Making 19:428-34 (Pubitemid 29474769)
12. Edwards A, Elwyn G, Mulley A (2002) Explaining risks: turning numerical data into meaningful pictures. BMJ 324:827-30 (Pubitemid 34280736)
13. Edwards A, Elwyn G, Hood K et al (2003) The development of COMRADE - a patient-based outcome measure to evaluate the effectiveness of risk communication and treatment decision making in consultations. Patient Educ Couns 50: 311-22 (Pubitemid 36945306)
14. Goldacre M, Duncan M, Cook-Mozaffari P et al (2006) Myocardial Infarction in England 1996-2004: Mortality Trends. South East England Public Health Observatory, Oxford
15. Goldman RE, Parker DR, Eaton CB et al (2006) Patients' perceptions of cholesterol, cardiovascular disease risk, and risk communication strategies. Ann Fam Med 4: 205-12 (Pubitemid 43824793)
16. Haynes RB, Sackett DL, Taylor DW et al (1978) Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med 299: 741-4 (Pubitemid 9040909)
17. Hollnagel H (1999) Explaining risk factors to patients during a general practice consultation. Conveying group-based epidemiological knowledge to individual patients. ScandJ Prim Health Care 17: 3-5
18. Misselbrook D, Armstrong D (2001) Patients' responses to risk information about the benefits of treating hypertension. Br J Gen Pract 51: 276-9 (Pubitemid 32293731)
19. Misselbrook D, Armstrong D (2002) Thinking about risk. Can doctors and patients talk the same language? Fam Pract 19: 1-2 (Pubitemid 34173266)
20. Nakao MA, Axelrod S (1983) Numbers are better than words. Verbal specifications of frequency have no place in medicine. Am J Med 74: 1061-5
21. Nic Gabhainn S, Kelleher CC, Naughton AM et al (1999) Socio-demographic variations in perspectives on cardiovascular disease and associated risk factors. Health Educ Res 14: 619-28 (Pubitemid 30015833)
22. Ohnishi M, Fukui T, Matsui K (2002) Interpretation of and preference for probability expressions among Japanese patients and physicians. Fam Pract 19: 7-11 (Pubitemid 34173268)
23. Paling J (2003) Strategies to help patients understand risks. BMJ 327:745-8
24. Peto R, Darby S, Deo H et al (2000) Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 321: 323-9 (Pubitemid 30496873)
25. Price HC, Dudley C, Barrow B et al (2009) Use of focus groups to develop methods to communicate cardiovascular disease risk and potential for risk reduction to people with type 2 diabetes. Fam Pract 26: 351-8
26. Rothman AJ, Kiviniemi MT (1999) Treating people with information: an analysis and review of approaches to communicating health risk information. J Natl Cancer Inst Monogr 25: 44-51
27. Shaw C, Abrams K, Marteau TM (1999) Psychological impact of predicting individuals' risks of illness: a systematic review. Soc Sci Med 49: 1571-98 (Pubitemid 29428059)
28. Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetes, other risk factots, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16: 434-44 (Pubitemid 23046633)